Novo Nordisk A/S Class B (NOVOb)

701.9
-10.2(-1.43%)
  • Volume:
    2,244,096
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    694.8 - 716.4
  • Type:Equity
  • Market:Denmark
  • ISIN:DK0060534915
  • S/N:1772564000

NOVOb Overview

Prev. Close
712.1
Day's Range
694.8-716.4
Revenue
134.61B
Open
712.1
52 wk Range
412.6-760.9
EPS
19.99
Volume
2,244,096
Market Cap
1.6T
Dividend (Yield)
9.35
(1.33%)
Average Volume (3m)
1,836,252
P/E Ratio
35.62
Beta
0.76
1-Year Change
70.77%
Shares Outstanding
2,280,607,268
Next Earnings Date
02 Feb 2022
What is your sentiment on Novo Nordisk A/S Class B?
or
Market is currently closed. Voting is open during market hours.

Novo Nordisk A/S Class B Company Profile

Employees
46982
Market
Denmark

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson’s diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyNeutralSellNeutralStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Buy
SummaryStrong BuyBuyStrong SellSellStrong Buy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.